H. Xu

发表

Central mu-opioid receptors are down-regulated in a rat model of cholestasis.

N. Bergasa, M. Swain, R. Rothman, 1992, Journal of hepatology.

Preliminary ligand binding data for subtypes of the delta opioid receptor in rat brain membranes.

K. Rice, R. Rothman, A. E. Jacobson, 1991, Life sciences.

Opioid peptide receptor studies. 14. Stereochemistry determines agonist efficacy and intrinsic efficacy in the [35S]GTP‐γ‐S functional binding assay

K. Rice, James B. Thomas, F. Carroll, 2001, Synapse.

Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.

S K Saini, K. Rice, R. Rothman, 1999, Journal of medicinal chemistry.

Probes for narcotic receptor-mediated phenomena. 20. Alteration of opioid receptor subtype selectivity of the 5-(3-hydroxyphenyl)morphans by application of the message-address concept: preparation of delta-opioid receptor ligands.

J. Flippen-Anderson, K. Rice, R. Rothman, 1995, Journal of medicinal chemistry.

Protective action of piperine against experimental gastric ulcer.

Yin Bai, Hong-ya Xu, Y. Bai, 2000, Acta pharmacologica Sinica.

Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3- methoxybenzyl]-N,N-diethylbenzamide (SNC 80): a highly selective, nonpeptide delta opioid receptor agonist.

J. Flippen-Anderson, K. Rice, R. Rothman, 1994, Journal of medicinal chemistry.

Potent 3-methylfentanyl analogs: morphine-like catalepsy and receptor binding characteristics.

Y. Zhu, J. Chen, Z. Chi, 1987, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

The potent opioid agonist, (+)-cis-3-methylfentanyl binds pseudoirreversibly to the opioid receptor complex in vitro and in vivo: evidence for a novel mechanism of action.

N. Greig, A. Newman, K. Rice, 1990, Life sciences.

Differential binding of opioid peptides and other drugs to two subtypes of opioid delta ncx binding sites in mouse brain: further evidence for delta receptor heterogeneity.

K. Rice, R. Rothman, B. de Costa, 1993, Peptides.

Endogenous opioids accumulate in plasma in a rat model of acute cholestasis.

N. Bergasa, M. Swain, R. Rothman, 1992, Gastroenterology.

Optically pure (-)-4-[(N-allyl-3-methyl-4-piperidinyl)phenyl-amino]-N,N-diethylbenzami de displays selective binding and full agonist activity for the delta opioid receptor.

S. Mascarella, F. Carroll, J. B. Thomas, 1999, Bioorganic & medicinal chemistry letters.

(+/-)-4-[(N-allyl-cis-3-methyl-4-piperidinyl)phenylamino]-N,N-diethylbenzamide displays selective binding for the delta opioid receptor.

S. Mascarella, F. Carroll, J. B. Thomas, 1999, Bioorganic & medicinal chemistry letters.

In vitro and in vivo characterization of [125I]iodomethyllycaconitine in the rat

H. Navarro, F. Carroll, P. Abraham, 2002, Synapse.

Ohmefentanyl--a new agonist for mu-opiate receptor.

J. Chen, Z. Chi, H. Xu, 1985, Scientia Sinica. Series B, Chemical, biological, agricultural, medical & earth sciences.

Synthesis and pharmacological characterization of [(125)I]iodomethyllycaconitine ([(125)I]iodo-MLA). A new ligand for the alpha(7) nicotinic acetylcholine receptor.

H. Navarro, F. Carroll, P. Abraham, 2000, Journal of medicinal chemistry.